Drug use as a driver of HIV Risks: Re-emerging and emerging issues


injection drug use, non-injection drug use, HIV/AIDS


Purpose of Review

We reviewed papers published in 2012–2013 that focused on re-emerging and emerging injection and non-injection drug use trends driving HIV risk behaviors and transmission in some parts of the world.

Recent Findings

While HIV incidence has declined in many countries, HIV epidemics remain at troubling levels among key drug using populations including females who inject drugs (FWID), FWID who trade sex, sex partners of people who inject drugs (SP-PWID), young PWID, and people who use non-injection drugs in a number of low- and middle- income countries such as in Central Asia, Eastern Europe, Southeast Asia, and parts of Africa.


HIV epidemics occur within contexts of global economic and political forces, including poverty, human rights violations, discrimination, drug policies, trafficking, and other multi-level risk environments. Trends of injection and non-injection drug use and risk environments driving HIV epidemics in Central Asia, Eastern Europe, Southeast Asia, and parts of Africa call for political will to improve HIV and substance use service delivery, access to combination HIV prevention, and harm reduction programs.

Original Publication Citation

El-Bassel, N., Shaw, S.A., Dasgupta, A., Strathdee, S.A. (2014). Drug use as a driver of HIV risks: Re-emerging and emerging issues. Current Opinion in HIV and AIDS, 9(2), 150-155.

Document Type

Peer-Reviewed Article

Publication Date



Current Opinion on HIV/AIDS




Family, Home, and Social Sciences


Social Work

University Standing at Time of Publication

Assistant Professor